Article
Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia.
Blood cells, molecules & diseases - 1 Jan 2015
Ibrahem Lamia, Mahfouz Rabab, Elhelw Loie, Abdsalam Eman M, Soliman Rehan
Abstract excerpt
Acute myeloid leukemia (AML) represents a heterogeneous group of malignancies with great variability in clinical course and response to therapy. Several molecular markers have been described that help to classify AML patients into risk groups. Mutations in DNA methyltransferase 3A (DNMT3A) gene were recently demonstrated in AML. Approximately 20% patients with AML carry DNMT3A gene mutations and were associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
